Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (681-690 of 874) with videos related to

Pageof 88
Sort By:
HIV Medicine|July 18, 2024
Psychosocial and sexual health among men with and without HIV who have sex with men: A cross-sectional nationwide study in DenmarkDitte Scofield, Morten Frisch, Mikael Andersson, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Early life stress induces social behavioral deficits and peripheral biomarker alterations in adolescence that perpetuate intergenerationallyJosephine C McGowan, Jed L Katzenstein, Natalie S Chace, et al.
HIV Medicine|June 11, 2015
Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general populationK Thorsteinsson, S Ladelund, S Jensen-Fangel, et al.
Frontiers in Immunology|October 10, 2022
Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort studyTerese L Katzenstein, Line D Rasmussen, Camilla Helberg Drabe, et al.
HIV Clinical Trials|December 17, 2013
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202Philip M Grant, Camlin Tierney, Chakra Budhathoki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patientsNancy S Shulman, Michael D Hughes, Mark A Winters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2012
Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern IndiaShanmugam Saravanan, Madhavan Vidya, Pachamuthu Balakrishnan, et al.
AIDS (London, England)|October 4, 2008
Bayesian network analyses of resistance pathways against efavirenz and nevirapineKoen Deforche, Ricardo J Camacho, Zehave Grossman, et al.
Plos One|February 14, 2023
Clinic-based SAMBA-II vs centralized laboratory viral load assays among HIV-1 infected children, adolescents and young adults in rural Zimbabwe: A randomized controlled trialVinie Kouamou, Rhoderick Machekano, Tichaona Mapangisana, et al.
The New England Journal of Medicine|August 11, 2001
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infectionM A Albrecht, R J Bosch, S M Hammer, et al.
Pageof 88

Showing results (681-690 of 874) with videos related to

Sort By:
Pageof 88
HIV Medicine|July 18, 2024
Psychosocial and sexual health among men with and without HIV who have sex with men: A cross-sectional nationwide study in DenmarkDitte Scofield, Morten Frisch, Mikael Andersson, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Early life stress induces social behavioral deficits and peripheral biomarker alterations in adolescence that perpetuate intergenerationallyJosephine C McGowan, Jed L Katzenstein, Natalie S Chace, et al.
HIV Medicine|June 11, 2015
Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general populationK Thorsteinsson, S Ladelund, S Jensen-Fangel, et al.
Frontiers in Immunology|October 10, 2022
Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort studyTerese L Katzenstein, Line D Rasmussen, Camilla Helberg Drabe, et al.
HIV Clinical Trials|December 17, 2013
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202Philip M Grant, Camlin Tierney, Chakra Budhathoki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patientsNancy S Shulman, Michael D Hughes, Mark A Winters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2012
Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern IndiaShanmugam Saravanan, Madhavan Vidya, Pachamuthu Balakrishnan, et al.
AIDS (London, England)|October 4, 2008
Bayesian network analyses of resistance pathways against efavirenz and nevirapineKoen Deforche, Ricardo J Camacho, Zehave Grossman, et al.
Plos One|February 14, 2023
Clinic-based SAMBA-II vs centralized laboratory viral load assays among HIV-1 infected children, adolescents and young adults in rural Zimbabwe: A randomized controlled trialVinie Kouamou, Rhoderick Machekano, Tichaona Mapangisana, et al.
The New England Journal of Medicine|August 11, 2001
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infectionM A Albrecht, R J Bosch, S M Hammer, et al.
Pageof 88